Other languages Solid Biosciences Inc.

Equities

SLDB

US83422E2046

Real-time Estimate Cboe BZX Other stock markets 01:09:42 2024-06-07 pm EDT			5-day change	1st Jan Change
8.49 ^USD	+9.97%		+1.15%	+36.07%

May. 15	Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label	Apr. 01
Solid Biosciences Inc. Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003	Apr. 01
Solid Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13
Solid Biosciences Inc. Announces Licensing Agreement with Armatus Bio for the Use of Aav-Slb101, A Proprietary, Muscle-Targeted Capsid, in the Development of an Rnai Therapy to Treat Fshd	Mar. 07
Solid Biosciences Gets FDA Orphan Drug Designation for Duchenne Drug Candidate	Jan. 16
Top Midday Gainers	Jan. 09
Solid Biosciences Shares Surge After Revealing $109 Million Private Placement	Jan. 09
Solid Biosciences Shares Fall After Surging Thursday; HC Wainwright Starts Coverage With Buy Rating	Dec. 08
Sector Update: Health Care Stocks Retreating Late Afternoon	Dec. 07
Top Midday Gainers	Dec. 07
Solid Biosciences Says FDA Grants Fast Track Designation to Duchenne Muscular Dystrophy Gene Therapy; Shares Rise	Dec. 07
Wall Street opnieuw hoger gesloten	Nov. 15
Wall Street weet openingswinsten vast te houden	Nov. 15
Wall Street op weg naar hogere start	Nov. 15
Wall Street Set to Extend Rally on Back of Cooling Inflation, Driving Premarket Gains for US Equity Futures	Nov. 15
Inflation, Retail Data Eyed as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednesday	Nov. 15
Top Premarket Gainers	Nov. 15
Futures wijzen verder omhoog	Nov. 15
Solid Biosciences New Drug Application for Duchenne Muscular Dystrophy Gets FDA Clearance; Shares Soar Premarket	Nov. 15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Solid Biosciences Inc.

Equities

SLDB

US83422E2046

Other languages

Filters